TrialThe lancet. HIV2025

ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study.

Deborah Persaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.